|
| |
Image Results
Loading...
Loading...
Tt-103MH Antihemorrhage Pages on BioPortfolio:
BioPortfolio BioCorporate Profile
innovative drug candidates, TH-103MH, a novel antihemorrhagic human recombinant protein to be use topically, and TT-105, a novel anticoagulant ...
http://www.bioportfolio.com/biocorporate/pdf/31064/thrombota...
|
BioPortfolio - ThromboTargets Corporation
Presently, two of Thrombotargets most innovative drug candidates, TT-103MH, a novel antihemorrhagic human recombinant protein to be use topically, ...
http://www.bioportfolio.com/biocorporate/31064-ThromboTarget...
|
Thrombotargets Corp. Announces the Membership of Its New ...
1 Jun 2007 ... development of our innovative technologies and drug candidates, specially TT -103MH, our Orphan Drug Designated antihemorrhagic protein”. ...
http://www.bioportfolio.com/biotech_news/Thrombotargets_6.ht...
|
Results from other life science and pharmaceutical sites:
|
